Menacalc, a quantitative method of metastasis assessment, as a prognostic marker for axillary node-negative breast cancer

被引：0

作者：

Catherine L. Forse

Seema Agarwal

Dushanthi Pinnaduwage

Frank Gertler

John S. Condeelis

Juan Lin

Xiaonan Xue

Kimberly Johung

Anna Marie Mulligan

Thomas E. Rohan

Shelley B. Bull

Irene L. Andrulis

机构：

[1] University of Toronto,Department of Laboratory Medicine and Pathobiology

[2] Yale University School of Medicine,Department of Pathology

[3] Georgetown University,Department of Pathology

[4] Mount Sinai Hospital,Lunenfeld

[5] Massachusetts Institute of Technology,Tanenbaum Research Institute

[6] Gruss Lupper Biophotonics Center,Department of Biology and Koch Institute for Integrative Cancer Research

[7] Integrated Imaging Program,Department of Anatomy and Structural Biology

[8] Albert Einstein College of Medicine,Department of Epidemiology and Population Health

[9] Albert Einstein College of Medicine,Department of Therapeutic Radiology

[10] Yale University School of Medicine,Laboratory Medicine Program

[11] University Health Network,Dalla Lana School of Public Health

[12] University of Toronto,Department of Molecular Genetics

[13] University of Toronto,Department of Pathology & Laboratory Medicine

[14] Mount Sinai Hospital,undefined

来源：

BMC Cancer | / 15卷

关键词：

Mena; Metastasis; Breast cancer; Axillary node negative; Prognostic marker;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

下载

共 50 条

[1] Menacalc, a Quantitative Method of Metastasis Assessment, as a Prognostic Marker for Axillary Node-Negative Breast Cancer
Forse, C. L.
Agarwal, S.
Pinnaduwage, D.
Gertler, F.
Condeelis, J.
Lin, J.
Xue, X.
Rohan, T. E.
Rumm, D. L.
Andrulis, I. L.
LABORATORY INVESTIGATION, 2014, 94 : 49A - 49A
[2] Menacalc, a quantitative method of metastasis assessment, as a prognostic marker for axillary node-negative breast cancer
Forse, Catherine L.
Agarwal, Seema
Pinnaduwage, Dushanthi
Gertler, Frank
Condeelis, John S.
Lin, Juan
Xue, Xiaonan
Johung, Kimberly
Mulligan, Anna Marie
Rohan, Thomas E.
Bull, Shelley B.
Andrulis, Irene L.
BMC CANCER, 2015, 15
[3] Menacalc, a Quantitative Method of Metastasis Assessment, as a Prognostic Marker for Axillary Node-Negative Breast Cancer
Forse, C. L.
Agarwal, S.
Pinnaduwage, D.
Gertler, F.
Condeelis, J.
Lin, J.
Xue, X.
Rohan, T. E.
Rimm, D. L.
Andrulis, I. L.
MODERN PATHOLOGY, 2014, 27 : 49A - 49A
[4] Axillary metastasis in clinically node-negative breast cancer
Ureyen, Orhan
Cavdar, Demet Kocatepe
Adibelli, Zehra Hilal
Ilhan, Enver
JOURNAL OF THE EGYPTIAN NATIONAL CANCER INSTITUTE, 2018, 30 (04) : 159 - 163
[5] PROGNOSTIC FACTORS IN AXILLARY NODE-NEGATIVE BREAST-CANCER
ZIELINSKI, CC
ONKOLOGIE, 1994, 17 (03): : 284 - 285
[6] Clinical relevance of prognostic factors in axillary node-negative breast cancer
Thomssen, C
Jänicke, F
Harbeck, N
ONKOLOGIE, 2003, 26 (05): : 438 - 445
[7] Urokinase plasminogen activator: a prognostic marker in breast cancer including patients with axillary node-negative disease
Duffy, MJ
Duggan, C
Mulcahy, HE
McDermott, EW
O'Higgins, NJ
CLINICAL CHEMISTRY, 1998, 44 (06) : 1177 - 1183
[8] Quantitative assessment of invasive mena isoforms (Menacalc) as an independent prognostic marker in breast cancer
Seema Agarwal
Frank B Gertler
Michele Balsamo
John S Condeelis
Robert L Camp
Xiaonan Xue
Juan Lin
Thomas E Rohan
David L Rimm
Breast Cancer Research, 14
[9] Quantitative assessment of invasive mena isoforms (Menacalc) as an independent prognostic marker in breast cancer
Agarwal, Seema
Gertler, Frank B.
Balsamo, Michele
Condeelis, John S.
Camp, Robert L.
Xue, Xiaonan
Lin, Juan
Rohan, Thomas E.
Rimm, David L.
BREAST CANCER RESEARCH, 2012, 14 (05):
[10] PROGNOSTIC FACTORS FOR RECURRENCE AND SURVIVAL IN AXILLARY NODE-NEGATIVE BREAST-CANCER
MCGUIRE, WL
CLARK, GM
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1989, 34 (1-6): : 145 - 148

← 1 2 3 4 5 →